Intuitive Surgical trades as part of the medical instruments and equipment industry and trades as part of the healthcare sector. The company CEO is Gary S. Guthart. Intuitive Surgical Inc designs, manufactures, markets da Vinci Surgical Systems, and related instruments. The da Vinci surgery, combines the benefits of minimally invasive surgery for patients with the ease of use, precision and dexterity of open surgery.
Previous Intraday Trading Performance:
The ISRG stock showed a previous change of 0.58% with an open at 475.39 and a close of 476.53. It reached an intraday high of 478.90 and a low of 471.63.
The stock has a market cap of $55.0b with 115.4m shares outstanding, of which the float is 114.5m shares. Trading volume reached 774,454 shares compared to its average volume of 998,816 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, Intuitive Surgical shares returned -1.38% and in the past 30 trading days it returned -18.24%. Over three months, it changed -13.89%. In one year it has changed 4.09% and within that year its 52-week high was 589.32 and its 52-week low was 430.24. ISRG stock is 10.76% above its 52 Week Low.
Our calculations show a 200 day moving average of 526.18 and a 50 day moving average of 531.57. Currently ISRG stock is trading -9.44% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
The last annual fiscal EPS for the company was reported at 9.49 that ended on 31st of December 2018, which according to the previous close, that is a PE of 50.21. Based on 2 analyst estimates, the consensus EPS for the next quarter is 2.26. The TTM EPS is 9.28, which comes to a TTM PE of 51.35. Historically, the PE high was 100.50 and the PE low was 20.70. If the stock reached its PE low, that would represent a price of 192.10, which is a decrease of -59.69%.
Below was the last reported quarterly diluted earnings per share:
|1st||Qtr of 2019||2.56|
|4th||Qtr of 2018||2.45|
|3rd||Qtr of 2018||2.45|
|2nd||Qtr of 2018||2.15|
|1st||Qtr of 2018||2.44|
Base on our calculations, the intrinsic value per share is 441.80, which means it may be overvalued by -7.86%.
Indicators to Watch:
The current calculated beta is 1.06.
Based on last reported financials, the company’s return on equity is 18.65%, return on assets is 15.93%, profit margin is 29.65%, price-to-sales is 14.21 and price-to-book is 7.83.
All scores are out of six:
0 :Valuation Score
4 :Past Performance Score
5 :Financial Strength Score
2 :Future Growth Score
0 :Dividend Score
2 :Overall Score